MPP1 mRNA level has been reported to be decreased in two atypical parkinsonian disorders (multiple system atrophy (MSA) and progressive supranuclear palsy (PSP)) and PD compared with healthy controls. This evidence concerns the gene MPP1 and Classical progressive supranuclear palsy.